Cargando…

Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals

Breast cancer is the cancer with the most incidence and mortality in women. microRNAs are emerging as novel prognosis/diagnostic tools. Our aim was to identify a serum microRNA signature useful to predict cancer development. We focused on studying the expression levels of 30 microRNAs in the serum o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feliciano, Andrea, González, Lucila, Garcia-Mayea, Yoelsis, Mir, Cristina, Artola, Mireia, Barragán, Nieves, Martín, Remedios, Altés, Anna, Castellvi, Josep, Benavente, Sergi, Ramón y Cajal, Santiago, Espinosa-Bravo, Martín, Cortés, Javier, Rubio, Isabel T., LLeonart, Matilde E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670964/ https://www.ncbi.nlm.nih.gov/pubmed/33224883 http://dx.doi.org/10.3389/fonc.2020.586268

Ejemplares similares

TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2020)

Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021)

miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer
por: Feliciano, Andrea, et al.
Publicado: (2017)

Autophagy Takes Center Stage as a Possible Cancer Hallmark
por: Alvarez-Meythaler, Jose G., et al.
Publicado: (2020)

The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)

Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022)

SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021)

Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
por: Kondoh, Hiroshi, et al.
Publicado: (2021)

miR-125b Acts as a Tumor Suppressor in Breast Tumorigenesis via Its Novel Direct Targets ENPEP, CK2-α, CCNJ, and MEGF9
por: Feliciano, Andrea, et al.
Publicado: (2013)

Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
por: Benavente, Sergi, et al.
Publicado: (2020)

RPLP1, a Crucial Ribosomal Protein for Embryonic Development of the Nervous System
por: Perucho, Laura, et al.
Publicado: (2014)

Ovarian Fibrosarcoma: Clinicopathologic Considerations about the Intraoperative and Post-Surgical Procedures
por: García Jiménez, Angel, et al.
Publicado: (2009)

MicroRNAs Regulate Key Effector Pathways of Senescence
por: Feliciano, Andrea, et al.
Publicado: (2011)

Impacto de la formación en entrevista motivacional para médicos: diseño y evaluación de un Programa Formativo (MOTIVA)
por: Barragán-Brun, Nieves, et al.
Publicado: (2021)

Beyond molecular tumor heterogeneity: protein synthesis takes control
por: Ramon y Cajal, Santiago, et al.
Publicado: (2018)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Bacterias y hongos fitopatógenos
por: Mayea Silverio, Sergio
Publicado: (1983)

Theophylline is able to partially revert cachexia in tumour-bearing rats
por: Olivan, Mireia, et al.
Publicado: (2012)

Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy
por: Lyakhovich, Alex, et al.
Publicado: (2016)

Abl Is Able to Inhibit Cell Engulfment
por: Robinson, Richard
Publicado: (2009)

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease
por: León, Rilda, et al.
Publicado: (2023)

Measuring health inequalities: a systematic review of widely used indicators and topics
por: Albert-Ballestar, Sergi, et al.
Publicado: (2021)

Effectiveness of Motivational Interviewing in improving lipid level in patients with dyslipidemia assisted by general practitioners: Dislip-EM study protocol
por: Pérula, Luis A, et al.
Publicado: (2011)

Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism
por: Khateb, Mamduh, et al.
Publicado: (2012)

Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics
por: Ramón y Cajal, Santiago, et al.
Publicado: (2019)

Perfectly Able
por: International, Lighthouse
Publicado: (2010)

Senescence induction; a possible cancer therapy
por: LLeonart, Matilde E, et al.
Publicado: (2009)

The role of prostate tumor overexpressed 1 in cancer progression
por: Cánovas, Verónica, et al.
Publicado: (2016)

ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination
por: Jones, Jill K, et al.
Publicado: (2023)

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
por: Sánchez, Ricardo, et al.
Publicado: (2022)

Lipoma of the Uterine Corpus: Exceptional Eventuality Combined with an Ovarian Thecoma
por: Vilallonga, R., et al.
Publicado: (2009)

SARS-CoV-2-encoded small RNAs are able to repress the host expression of SERINC5 to facilitate viral replication
por: Meseguer, Salvador, et al.
Publicado: (2023)

Is the Scale for Measuring Motivational Interviewing Skills a valid and reliable instrument for measuring the primary care professionals motivational skills?: EVEM study protocol
por: Pérula, Luis Á, et al.
Publicado: (2012)

Clinical implications of intratumor heterogeneity: challenges and opportunities
por: Ramón y Cajal, Santiago, et al.
Publicado: (2020)

Otologic, audiometric and speech findings in patients undergoing surgery for cleft palate
por: Garcia-Vaquero, Cristina, et al.
Publicado: (2018)

Remodeling the tumor microenvironment to overcome treatment resistance in HPV-negative head and neck cancer
por: Benavente, Sergi
Publicado: (2023)

Editorial: Sphingolipid metabolism and cancer
por: Ivanova, Margarita M., et al.
Publicado: (2022)

The Functional Interplay Between the t(9;22)-Associated Fusion Proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-Positive Acute Lymphatic Leukemia
por: Rafiei, Anahita, et al.
Publicado: (2015)

Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1(T315I) and BCR-ABL1(T315I-E255K)
por: Mian, Afsar Ali, et al.
Publicado: (2021)

Effectiveness of motivational interviewing in patients with dyslipidemia: a randomized cluster trial
por: Bóveda-Fontán, Julia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cdvpsojv09hp407v8jm4tt9jhd